glp-1 agonists and sglt2 inhibitors combination Perspectives in weight control in diabetes – GLP-1–glucagon dual agonism Combining glucagon-like peptide-1 receptor agonists
Description
Their main mechanisms include increasing insulin release, enhancing insulin sensitivity, reducing dietary sugar intake, etc
References 1.American Diabetes Association Standards of medical care in diabetes2013
9 They should be administrated by injection except for oral semaglutide, limiting their clinical application
abuzek K, Kozowski M, Szkudapski D, Sikorska P, Kozowska M, Okopie B
I think it sends a really terrible message to the public, which just kind of reinstates the stigma around obesity, saying that this is not a disease, this is a choice, she said
